PMID: 8949448Sep 1, 1996Paper

Cutaneous lymphocytic vasculitis in acute myeloid leukaemia

The British Journal of Dermatology
A M FarrellJ J Cream

Abstract

We report a 63-year-old woman who presented with an 8-week history of widespread indurated, purpuric lesions associated with weight loss of 7 kg and several episodes of epistaxis. A skin biopsy demonstrated a lymphocytic vasculitis with haemorrhage and parakeratosis. A blood film and bone marrow examination showed features of a myelodysplastic syndrome in transformation to acute myeloid leukaemia. Leucocytoclastic vasculitis and polyarteritis nodosa occur in association with acute myeloid leukaemia, but the association with lymphocytic vasculitis is new.

References

Mar 1, 1992·European Journal of Pediatrics·H AkitaY Kuroda
Jan 1, 1991·British Journal of Haematology·M S DoutreJ Reiffers
Aug 1, 1990·Histopathology·R Chetty
Jan 1, 1986·Postgraduate Medical Journal·A C LeungJ M Boulton-Jones
Dec 1, 1988·Journal of the American Academy of Dermatology·J L JorizzoB Leshin
Nov 1, 1986·Journal of Pediatric Surgery·W R Clark, S A Kramer
May 1, 1981·Irish Journal of Medical Science·W MolloyM Molloy
Jul 1, 1984·Journal of the American Academy of Dermatology·W P SuC Y Li
Apr 1, 1984·Journal of Cutaneous Pathology·M C Massa, W P Su
Oct 1, 1993·Journal of Cutaneous Pathology·J K Desch, B R Smoller
Apr 1, 1993·Journal of Autoimmunity·P W MathiesonD B Oliveira

❮ Previous
Next ❯

Citations

Sep 1, 1997·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·J T Lie
Feb 24, 2001·The Laryngoscope·A C GoldmanJ Lim
Oct 9, 2002·Journal of Pediatric Hematology/oncology·Tang-Her JaingIou-Jih Hung
Nov 15, 2011·Rheumatic Diseases Clinics of North America·Hyon Ju Park, Prabha Ranganathan
May 24, 2006·Clinical and Experimental Dermatology·S ShankarN P Burrows
May 27, 2004·Leukemia & Lymphoma·Mine CabukErtan Ozdemir

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Journal of the American Academy of Dermatology
H J Choi, S K Hann
Clinical and Experimental Dermatology
A M FarellC B Bunker
Clinical and Experimental Dermatology
S BrigantiM Picardo
© 2021 Meta ULC. All rights reserved